152 related articles for article (PubMed ID: 25622556)
1. Haemophilia-related outcome after liver transplantation and treatment with sofosbuvir/ribavirin in a HCV-HIV coinfected man with liver failure and hepatocellular carcinoma.
Stemberger M; Seybold U; Eberle J; Denk G; Kolligs F; Kaspar M; Guba M; Pichler M; Spannagl M
Haemophilia; 2015 Mar; 21(2):e131-e133. PubMed ID: 25622556
[No Abstract] [Full Text] [Related]
2. Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study.
Curry MP; Forns X; Chung RT; Terrault NA; Brown R; Fenkel JM; Gordon F; O'Leary J; Kuo A; Schiano T; Everson G; Schiff E; Befeler A; Gane E; Saab S; McHutchison JG; Subramanian GM; Symonds WT; Denning J; McNair L; Arterburn S; Svarovskaia E; Moonka D; Afdhal N
Gastroenterology; 2015 Jan; 148(1):100-107.e1. PubMed ID: 25261839
[TBL] [Abstract][Full Text] [Related]
3. Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation.
Charlton M; Gane E; Manns MP; Brown RS; Curry MP; Kwo PY; Fontana RJ; Gilroy R; Teperman L; Muir AJ; McHutchison JG; Symonds WT; Brainard D; Kirby B; Dvory-Sobol H; Denning J; Arterburn S; Samuel D; Forns X; Terrault NA
Gastroenterology; 2015 Jan; 148(1):108-17. PubMed ID: 25304641
[TBL] [Abstract][Full Text] [Related]
4. Sofosbuvir, simeprevir, and ribavirin for the treatment of hepatitis C virus recurrence in human immunodeficiency virus/hepatitis C virus-coinfected liver transplant recipients.
Campos-Varela I; Straley S; Agudelo EZ; Carlson L; Terrault NA
Liver Transpl; 2015 Feb; 21(2):272-4. PubMed ID: 25332190
[No Abstract] [Full Text] [Related]
5. Sofosbuvir treatment in the pre and post liver transplantation phase: the sooner, the better.
Aghemo A; Donato MF
Gastroenterology; 2015 Jan; 148(1):13-6. PubMed ID: 25451651
[No Abstract] [Full Text] [Related]
6. Quantum leaps, microeconomics, and the treatment of patients with hepatitis C and HIV coinfection.
Saag MS
JAMA; 2014 Jul 23-30; 312(4):347-8. PubMed ID: 25038351
[No Abstract] [Full Text] [Related]
7. Sofosbuvir and Ribavirin for Treatment of Chronic Hepatitis C in Patients Coinfected With Hepatitis C Virus and HIV: The Impact on Patient-Reported Outcomes.
Younossi ZM; Stepanova M; Sulkowski M; Naggie S; Puoti M; Orkin C; Hunt SL
J Infect Dis; 2015 Aug; 212(3):367-77. PubMed ID: 25583164
[TBL] [Abstract][Full Text] [Related]
8. Ledipasvir-sofosbuvir for 6 weeks to treat acute hepatitis C virus genotype 1 or 4 infection in patients with HIV coinfection: an open-label, single-arm trial.
Rockstroh JK; Bhagani S; Hyland RH; Yun C; Dvory-Sobol H; Zheng W; Brainard DM; Ingiliz P; Lutz T; Boesecke C; Nelson M
Lancet Gastroenterol Hepatol; 2017 May; 2(5):347-353. PubMed ID: 28397698
[TBL] [Abstract][Full Text] [Related]
9. HIV and HCV coinfection in haemophilia.
Wilde JT
Haemophilia; 2004 Jan; 10(1):1-8. PubMed ID: 14962214
[TBL] [Abstract][Full Text] [Related]
10. HIV-hepatitis C co-infection.
Hayward P
Lancet Infect Dis; 2015 Apr; 15(4):382. PubMed ID: 25809897
[No Abstract] [Full Text] [Related]
11. Sofosbuvir and ribavirin use in wait-listed patients with hepatitis C should be selective.
Price JC; Terrault NA
Liver Int; 2015 Jan; 35(1):7-8. PubMed ID: 25183500
[No Abstract] [Full Text] [Related]
12. Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study.
Molina JM; Orkin C; Iser DM; Zamora FX; Nelson M; Stephan C; Massetto B; Gaggar A; Ni L; Svarovskaia E; Brainard D; Subramanian GM; McHutchison JG; Puoti M; Rockstroh JK;
Lancet; 2015 Mar; 385(9973):1098-106. PubMed ID: 25659285
[TBL] [Abstract][Full Text] [Related]
13. HCV/HIV Coinfection: A New Treatment Paradigm.
Kwo PY; Agrawal S
Gastroenterology; 2015 Jun; 148(7):1470-1. PubMed ID: 25935524
[No Abstract] [Full Text] [Related]
14. Efficacy of sofosbuvir-based therapies in HIV/HCV infected patients and persons who inject drugs.
Puoti M; Panzeri C; Rossotti R; Baiguera C
Dig Liver Dis; 2014 Dec; 46 Suppl 5():S206-11. PubMed ID: 25458781
[TBL] [Abstract][Full Text] [Related]
15. Regression of an HCV-associated disseminated marginal zone lymphoma under IFN-free antiviral treatment.
Sultanik P; Klotz C; Brault P; Pol S; Mallet V
Blood; 2015 Apr; 125(15):2446-7. PubMed ID: 25858892
[No Abstract] [Full Text] [Related]
16. Is time to treat for HCV all the HIV/HCV co-infected hemophiliacs?
Franchini M
Hematology; 2006 Jun; 11(3):209-13. PubMed ID: 17325964
[TBL] [Abstract][Full Text] [Related]
17. Sofosbuvir/ledipasvir and ribavirin tolerability and efficacy in pediatric liver transplant recipients.
Huysentruyt K; Stephenne X; Varma S; Scheers I; Leclercq G; Smets F; Sokal EM
Liver Transpl; 2017 Apr; 23(4):552-553. PubMed ID: 28006874
[No Abstract] [Full Text] [Related]
18. Viable strategies to facilitate liver transplantation for human immunodeficiency virus coinfection.
Stock PG; Fung J
Liver Transpl; 2009 Sep; 15(9):1003-6. PubMed ID: 19718639
[No Abstract] [Full Text] [Related]
19. Efficacy and safety of direct antiviral agents in a cohort of cirrhotic HCV/HIV-coinfected patients.
Navarro J; Laguno M; Vilchez HH; Guardiola JM; Carrion JA; Force L; Cairó M; Cifuentes C; Vilaró J; Cucurull J; Marco A; Roget M; Erice E; Crespo M;
J Antimicrob Chemother; 2017 Oct; 72(10):2850-2856. PubMed ID: 29091196
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment with sofosbuvir of fibrosing cholestatic hepatitis C after liver transplantation in an HIV-HCV-coinfected patient.
Borentain P; Colson P; Dhiver C; Gregoire E; Hardwigsen J; Botta-Fridlund D; Garcia S; Gerolami R
Antivir Ther; 2015; 20(3):353-6. PubMed ID: 25105441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
